| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.726 | 0.005 | 0.798 | 5 Hydroxytryptamine release stimulant | 0.798 0.004 CID_10890006 | CID_10890006 | |
| 0.551 | 0.004 | 0.634 | Cyclooxygenase inhibitor | 0.634 0.004 CID_10890006 | CID_10890006 | |
| 0.56 | 0.026 | 0.728 | Antiobesity | 0.728 0.009 CID_10890006 | CID_10890006 | |
| 0.563 | 0.034 | 0.624 | Analgesic | 0.624 0.023 CID_10890006 | CID_10890006 | |
| 0.514 | 0.004 | 0.597 | Cyclooxygenase 2 inhibitor | 0.597 0.004 CID_10890006 | CID_10890006 | |
| 0.494 | 0.004 | 0.494 | Tyrosine 3 hydroxylase inhibitor | 0.458 0.005 CID_10890006 | ||
| 0.428 | 0.004 | 0.428 | Dopamine D3 antagonist | 0.14 0.017 CID_10890006 | ||
| 0.405 | 0.006 | 0.405 | Insulin secretagoues | 0.231 0.024 CID_10890006 | ||
| 0.42 | 0.025 | 0.436 | HERG channel blocker | 0.436 0.022 CID_10890006 | CID_10890006 | |
| 0.413 | 0.027 | 0.413 | Cardiotonic | 0.258 0.077 CID_10890006 | ||
| 0.389 | 0.015 | 0.455 | Non-steroidal antiinflammatory agent | 0.455 0.009 CID_10890006 | CID_10890006 | |
| 0.398 | 0.027 | 0.404 | Potassium channel (Voltage-sensitive) blocker | 0.404 0.026 CID_10890006 | CID_10890006 | |
| 0.367 | 0.005 | 0.367 | Alpha 2a adrenoreceptor antagonist | 0.318 0.006 CID_10890006 | ||
| 0.371 | 0.008 | 0.462 | Cyclooxygenase 1 inhibitor | 0.462 0.005 CID_10890006 | CID_10890006 | |
| 0.432 | 0.074 | 0.441 | Cyclophilin D inhibitor | 0.441 0.07 CID_10890006 | CID_10890006 | |
| 0.411 | 0.056 | 0.411 | Toll-Like receptor agonist | 0.345 0.085 CID_10890006 | ||
| 0.406 | 0.058 | 0.406 | Toll-Like receptor 7 agonist | 0.347 0.083 CID_10890006 | ||
| 0.441 | 0.115 | 0.515 | Antiinflammatory | 0.515 0.081 CID_10890006 | CID_10890006 | |
| 0.341 | 0.017 | 0.341 | Diuretic | 0.309 0.021 CID_10890006 | ||
| 0.318 | 0.01 | 0.318 | Dopamine D2 antagonist | 0.085 0.037 CID_10890006 | ||
| 0.318 | 0.012 | 0.318 | Antipruritic | 0.194 0.053 CID_10890006 | ||
| 0.315 | 0.011 | 0.315 | Dopamine antagonist | 0.09 0.042 CID_10890006 | ||
| 0.31 | 0.026 | 0.31 | Gastrin inhibitor | 0.273 0.055 CID_10890006 | ||
| 0.291 | 0.01 | 0.291 | Alpha 2b adrenoreceptor antagonist | 0.209 0.022 CID_10890006 | ||
| 0.265 | 0.004 | 0.265 | Prolactin inhibitor | 0.158 0.019 CID_10890006 | ||
| 0.265 | 0.005 | 0.265 | Alpha 1 adrenoreceptor agonist | 0.158 0.009 CID_10890006 | ||
| 0.262 | 0.013 | 0.262 | Toll-Like receptor antagonist | 0.214 0.026 CID_10890006 | ||
| 0.259 | 0.018 | 0.259 | 5 Hydroxytryptamine 2B antagonist | 0.163 0.036 CID_10890006 | ||
| 0.262 | 0.023 | 0.262 | 5 Hydroxytryptamine antagonist | 0.179 0.039 CID_10890006 | ||
| 0.306 | 0.072 | 0.37 | Nootropic | 0.37 0.047 CID_10890006 | CID_10890006 | |
| 0.237 | 0.005 | 0.237 | Pregnane X receptor agonist | 0.217 0.007 CID_10890006 | ||
| 0.241 | 0.012 | 0.241 | Alpha 2 adrenoreceptor antagonist | 0.213 0.016 CID_10890006 | ||
| 0.332 | 0.107 | 0.42 | MAP kinase kinase 6 inhibitor | 0.42 0.047 CID_10890006 | CID_10890006 | |
| 0.302 | 0.077 | 0.302 | Sodium/bile acid cotransporter inhibitor | 0.3 0.079 CID_10890006 | ||
| 0.27 | 0.054 | 0.27 | 5 Hydroxytryptamine 1E antagonist | 0.232 0.095 CID_10890006 | ||
| 0.234 | 0.02 | 0.234 | Calcium channel blocker | 0.151 0.058 CID_10890006 | ||
| 0.218 | 0.007 | 0.218 | Phosphodiesterase 4B inhibitor | 0.2 0.008 CID_10890006 | ||
| 0.213 | 0.006 | 0.213 | Cannabinoid CB2 receptor agonist | 0.055 0.037 CID_10890006 | ||
| 0.21 | 0.015 | 0.21 | Calcium channel (voltage-sensitive) blocker | 0.123 0.053 CID_10890006 | ||
| 0.202 | 0.008 | 0.269 | Alpha adrenoreceptor agonist | 0.269 0.005 CID_10890006 | CID_10890006 | |
| 0.204 | 0.011 | 0.204 | CC chemokine receptor antagonist | 0.085 0.046 CID_10890006 | ||
| 0.204 | 0.017 | 0.204 | Alpha 2c adrenoreceptor antagonist | 0.147 0.034 CID_10890006 | ||
| 0.22 | 0.036 | 0.241 | 5 Hydroxytryptamine 3E antagonist | 0.241 0.02 CID_10890006 | CID_10890006 | |
| 0.195 | 0.013 | 0.195 | 5 Hydroxytryptamine 7 antagonist | 0.178 0.015 CID_10890006 | ||
| 0.212 | 0.031 | 0.212 | Toll-Like receptor 9 antagonist | 0.18 0.045 CID_10890006 | ||
| 0.196 | 0.018 | 0.196 | Calcium channel N-type blocker | 0.155 0.035 CID_10890006 | ||
| 0.182 | 0.005 | 0.243 | Glycine transporter inhibitor | 0.243 0.004 CID_10890006 | CID_10890006 | |
| 0.194 | 0.018 | 0.216 | Ca(v)2.2 blocker | 0.216 0.014 CID_10890006 | CID_10890006 | |
| 0.244 | 0.069 | 0.244 | Potassium channel blocker | 0.199 0.093 CID_10890006 | ||
| 0.204 | 0.029 | 0.204 | 5 Hydroxytryptamine 2 antagonist | 0.142 0.047 CID_10890006 | ||
| 0.178 | 0.004 | 0.192 | Liver X receptor agonist | 0.192 0.004 CID_10890006 | CID_10890006 | |
| 0.174 | 0.005 | 0.174 | CC chemokine 2 receptor antagonist | 0.104 0.012 CID_10890006 | ||
| 0.18 | 0.016 | 0.229 | Phosphodiesterase IV inhibitor | 0.229 0.009 CID_10890006 | CID_10890006 | |
| 0.184 | 0.022 | 0.184 | Chemokine receptor antagonist | 0.092 0.071 CID_10890006 | ||
| 0.169 | 0.007 | 0.169 | Cannabinoid CB2 receptor antagonist | |||
| 0.165 | 0.005 | 0.19 | Aldosterone antagonist | 0.19 0.004 CID_10890006 | CID_10890006 | |
| 0.227 | 0.069 | 0.239 | Peptidyltransferase inhibitor | 0.239 0.059 CID_10890006 | CID_10890006 | |
| 0.163 | 0.011 | 0.163 | Cannabinoid receptor agonist | |||
| 0.153 | 0.004 | 0.175 | Liver X receptor antagonist | 0.175 0.004 CID_10890006 | CID_10890006 | |
| 0.151 | 0.004 | 0.151 | CC chemokine 5 receptor agonist | 0.101 0.021 CID_10890006 | ||
| 0.19 | 0.047 | 0.19 | Acetylcholine M1 receptor antagonist | 0.146 0.078 CID_10890006 | ||
| 0.149 | 0.008 | 0.149 | Viral attachment inhibitor | 0.087 0.036 CID_10890006 | ||
| 0.143 | 0.004 | 0.143 | G protein-coupled receptor agonist | 0.071 0.01 CID_10890006 | ||
| 0.216 | 0.077 | 0.285 | EphB2 antagonist | 0.285 0.041 CID_10890006 | CID_10890006 | |
| 0.224 | 0.086 | 0.224 | Vasodilator | 0.217 0.092 CID_10890006 | ||
| 0.234 | 0.098 | 0.396 | 5 Hydroxytryptamine uptake stimulant | 0.396 0.015 CID_10890006 | CID_10890006 | |
| 0.257 | 0.122 | 0.261 | Vasodilator, peripheral | 0.261 0.12 CID_10890006 | CID_10890006 | |
| 0.137 | 0.004 | 0.137 | Liver X receptor beta agonist | 0.089 0.005 CID_10890006 | ||
| 0.308 | 0.185 | 0.308 | Caspase 9 stimulant | 0.28 0.217 CID_10890006 | ||
| 0.162 | 0.041 | 0.162 | Nav1.3 sodium channel blocker | |||
| 0.125 | 0.005 | 0.125 | Liver X receptor alpha agonist | 0.102 0.005 CID_10890006 | ||
| 0.137 | 0.017 | 0.137 | Dopamine agonist | |||
| 0.148 | 0.029 | 0.148 | 5 Hydroxytryptamine 2A antagonist | 0.106 0.044 CID_10890006 | ||
| 0.123 | 0.005 | 0.123 | CC chemokine 5 receptor antagonist | 0.045 0.043 CID_10890006 | ||
| 0.145 | 0.028 | 0.145 | 5 Hydroxytryptamine 2C antagonist | 0.113 0.039 CID_10890006 | ||
| 0.161 | 0.044 | 0.161 | Sphingosine 1-phosphate receptor 5 antagonist | 0.139 0.08 CID_10890006 | ||
| 0.214 | 0.097 | 0.214 | Aldehyde oxidase inhibitor | |||
| 0.256 | 0.14 | 0.296 | Calcium channel activator | 0.296 0.096 CID_10890006 | CID_10890006 | |
| 0.118 | 0.003 | 0.153 | Alpha 1d adrenoreceptor agonist | 0.153 0.002 CID_10890006 | CID_10890006 | |
| 0.139 | 0.024 | 0.139 | Alpha 1b adrenoreceptor antagonist | 0.061 0.06 CID_10890006 | ||
| 0.147 | 0.038 | 0.147 | Alpha adrenoreceptor antagonist | 0.085 0.067 CID_10890006 | ||
| 0.112 | 0.004 | 0.112 | Glucose-dependent insulinotropic receptor agonist | 0.063 0.007 CID_10890006 | ||
| 0.122 | 0.017 | 0.122 | Epoxide hydrolase inhibitor | 0.093 0.03 CID_10890006 | ||
| 0.123 | 0.019 | 0.123 | Dopamine D1 antagonist | 0.061 0.048 CID_10890006 | ||
| 0.239 | 0.135 | 0.261 | Antithrombotic | 0.261 0.118 CID_10890006 | CID_10890006 | |
| 0.307 | 0.203 | 0.329 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.329 0.175 CID_10890006 | CID_10890006 | |
| 0.115 | 0.013 | 0.115 | Ca(v)3.1 blocker | 0.085 0.047 CID_10890006 | ||
| 0.121 | 0.021 | 0.121 | Cannabinoid receptor antagonist | |||
| 0.103 | 0.004 | 0.103 | Liver X receptor beta antagonist | 0.086 0.004 CID_10890006 | ||
| 0.118 | 0.019 | 0.118 | Alpha 1d adrenoreceptor antagonist | |||
| 0.116 | 0.02 | 0.14 | Nicotinic alpha4beta2 receptor antagonist | 0.14 0.01 CID_10890006 | CID_10890006 | |
| 0.1 | 0.005 | 0.11 | Alpha 1b adrenoreceptor agonist | 0.11 0.004 CID_10890006 | CID_10890006 | |
| 0.108 | 0.013 | 0.108 | Phosphodiesterase 4C inhibitor | 0.108 0.013 CID_10890006 | ||
| 0.226 | 0.134 | 0.226 | Thyroid hormone beta antagonist | |||
| 0.247 | 0.157 | 0.247 | Histamine release inhibitor | |||
| 0.13 | 0.042 | 0.13 | Antiadrenergic | |||
| 0.092 | 0.004 | 0.107 | Liver X receptor alpha antagonist | 0.107 0.004 CID_10890006 | CID_10890006 | |
| 0.113 | 0.026 | 0.114 | 5 Hydroxytryptamine 1F antagonist | 0.114 0.025 CID_10890006 | CID_10890006 | |
| 0.127 | 0.041 | 0.127 | Adrenaline antagonist | |||
| 0.118 | 0.033 | 0.118 | Lanosterol 14 alpha demethylase inhibitor | 0.115 0.035 CID_10890006 | ||
| 0.099 | 0.015 | 0.201 | Alpha 2 adrenoreceptor agonist | 0.201 0.004 CID_10890006 | CID_10890006 | |
| 0.099 | 0.016 | 0.099 | Sigma receptor antagonist | |||
| 0.1 | 0.019 | 0.105 | Dopamine uptake inhibitor | 0.105 0.017 CID_10890006 | CID_10890006 | |
| 0.201 | 0.12 | 0.222 | MAP kinase kinase 3 inhibitor | 0.222 0.071 CID_10890006 | CID_10890006 | |
| 0.14 | 0.059 | 0.14 | Cholinergic antagonist | 0.124 0.07 CID_10890006 | ||
| 0.138 | 0.057 | 0.138 | Acetylcholine antagonist | 0.123 0.067 CID_10890006 | ||
| 0.087 | 0.007 | 0.087 | Prolactin release inhibitor | |||
| 0.102 | 0.024 | 0.102 | Calcium channel L-type blocker | |||
| 0.084 | 0.007 | 0.135 | Glycine transporter 1 inhibitor | 0.135 0.004 CID_10890006 | CID_10890006 | |
| 0.223 | 0.147 | 0.223 | Ca(v)3.3 blocker | |||
| 0.156 | 0.08 | 0.161 | Interleukin 6 antagonist | 0.161 0.075 CID_10890006 | CID_10890006 | |
| 0.22 | 0.145 | 0.22 | Thyroid hormone antagonist | |||
| 0.132 | 0.057 | 0.132 | Acetylcholine muscarinic antagonist | |||
| 0.097 | 0.022 | 0.097 | Acetylcholine M5 receptor agonist | 0.081 0.034 CID_10890006 | ||
| 0.205 | 0.131 | 0.205 | Transcription factor STAT inhibitor | |||
| 0.111 | 0.038 | 0.115 | ABCA1 expression enhancer | 0.115 0.035 CID_10890006 | CID_10890006 | |
| 0.084 | 0.011 | 0.084 | Dopamine D5 antagonist | |||
| 0.139 | 0.068 | 0.145 | Proto-oncogene tyrosine-protein kinase Yes inhibitor | 0.145 0.064 CID_10890006 | CID_10890006 | |
| 0.085 | 0.015 | 0.085 | Potassium channel intermediate-conductance Ca-activated blocker | |||
| 0.081 | 0.011 | 0.119 | Growth hormone secretagogue receptor agonist | 0.119 0.005 CID_10890006 | CID_10890006 | |
| 0.083 | 0.013 | 0.083 | Dopamine D2 agonist | |||
| 0.076 | 0.01 | 0.076 | Dopamine D3 agonist | |||
| 0.114 | 0.049 | 0.114 | Bronchodilator | |||
| 0.092 | 0.029 | 0.172 | 5 Hydroxytryptamine uptake inhibitor | 0.172 0.013 CID_10890006 | CID_10890006 | |
| 0.066 | 0.004 | 0.089 | Alpha 1a adrenoreceptor agonist | 0.089 0.003 CID_10890006 | CID_10890006 | |
| 0.094 | 0.034 | 0.129 | Focal adhesion kinase 1 inhibitor | 0.129 0.014 CID_10890006 | CID_10890006 | |
| 0.166 | 0.106 | 0.234 | Focal adhesion kinase 2 inhibitor | 0.234 0.046 CID_10890006 | CID_10890006 | |
| 0.084 | 0.027 | 0.084 | Acetylcholine M2 receptor antagonist | 0.057 0.048 CID_10890006 | ||
| 0.099 | 0.041 | 0.099 | Neuropeptide Y antagonist | 0.077 0.063 CID_10890006 | ||
| 0.063 | 0.006 | 0.105 | Phenylethanolamine N methyltransferase inhibitor | 0.105 0.003 CID_10890006 | CID_10890006 | |
| 0.072 | 0.015 | 0.088 | DNA helicase inhibitor | 0.088 0.008 CID_10890006 | CID_10890006 | |
| 0.079 | 0.023 | 0.139 | 5 Hydroxytryptamine 6 antagonist | 0.139 0.007 CID_10890006 | CID_10890006 | |
| 0.08 | 0.027 | 0.171 | Adrenaline uptake inhibitor | 0.171 0.008 CID_10890006 | CID_10890006 | |
| 0.097 | 0.047 | 0.158 | Acetylcholine M3 receptor agonist | 0.158 0.015 CID_10890006 | CID_10890006 | |
| 0.057 | 0.007 | 0.058 | Cathepsin F inhibitor | 0.058 0.006 CID_10890006 | CID_10890006 | |
| 0.067 | 0.018 | 0.189 | Nicotinic receptor alpha4 subunit antagonist | 0.189 0.004 CID_10890006 | CID_10890006 | |
| 0.069 | 0.021 | 0.122 | Dopamine transporter inhibitor | 0.122 0.008 CID_10890006 | CID_10890006 | |
| 0.051 | 0.003 | 0.051 | CXC chemokine 5 receptor antagonist | 0.018 0.012 CID_10890006 | ||
| 0.071 | 0.024 | 0.075 | Phosphodiesterase 4A inhibitor | 0.075 0.022 CID_10890006 | CID_10890006 | |
| 0.058 | 0.013 | 0.078 | Dopamine D5 agonist | 0.078 0.006 CID_10890006 | CID_10890006 | |
| 0.059 | 0.014 | 0.059 | Cytokine production stimulant | |||
| 0.191 | 0.147 | 0.191 | Transcription factor STAT3 inhibitor | |||
| 0.063 | 0.022 | 0.098 | Dipeptidyl peptidase inhibitor | 0.098 0.009 CID_10890006 | CID_10890006 | |
| 0.072 | 0.033 | 0.072 | Cannabinoid CB1 receptor agonist | |||
| 0.083 | 0.045 | 0.083 | Phosphodiesterase 4D inhibitor | 0.083 0.045 CID_10890006 | ||
| 0.101 | 0.065 | 0.101 | Nav1.1 sodium channel blocker | |||
| 0.116 | 0.081 | 0.119 | Sphingosine 1-phosphate receptor 4 antagonist | 0.119 0.074 CID_10890006 | CID_10890006 | |
| 0.085 | 0.051 | 0.098 | Adrenaline agonist | 0.098 0.038 CID_10890006 | CID_10890006 | |
| 0.084 | 0.051 | 0.084 | Alpha 1 adrenoreceptor antagonist | |||
| 0.056 | 0.023 | 0.056 | Histamine H3 receptor antagonist | |||
| 0.041 | 0.01 | 0.041 | Epoxide hydrolase 1 inhibitor | 0.039 0.012 CID_10890006 | ||
| 0.034 | 0.004 | 0.042 | Sodium/hydrogen exchanger inhibitor | 0.042 0.004 CID_10890006 | CID_10890006 | |
| 0.105 | 0.076 | 0.105 | Acetylcholine release stimulant | |||
| 0.075 | 0.047 | 0.075 | Potassium channel (Tandem pore domain) blocker | |||
| 0.091 | 0.063 | 0.091 | Antihistaminic | |||
| 0.071 | 0.046 | 0.071 | 5 Hydroxytryptamine 1A antagonist | |||
| 0.076 | 0.051 | 0.076 | Acetylcholine M4 receptor antagonist | |||
| 0.037 | 0.013 | 0.041 | 11-Beta-hydroxysteroid dehydrogenase 2 inhibitor | 0.041 0.011 CID_10890006 | CID_10890006 | |
| 0.038 | 0.014 | 0.079 | Dipeptidyl peptidase I inhibitor | 0.079 0.005 CID_10890006 | CID_10890006 | |
| 0.052 | 0.028 | 0.052 | 11-Beta-hydroxysteroid dehydrogenase 1 inhibitor | 0.041 0.039 CID_10890006 | ||
| 0.106 | 0.084 | 0.106 | Estrogen antagonist | |||
| 0.057 | 0.035 | 0.093 | Bromodomain-containing protein 4 inhibitor | 0.093 0.015 CID_10890006 | CID_10890006 | |
| 0.056 | 0.035 | 0.096 | Myc inhibitor | 0.096 0.008 CID_10890006 | CID_10890006 | |
| 0.041 | 0.02 | 0.041 | Delayed rectifier potassium channel blocker | |||
| 0.06 | 0.039 | 0.063 | Ca(v)3.2 blocker | 0.063 0.032 CID_10890006 | CID_10890006 | |
| 0.043 | 0.022 | 0.043 | GABA uptake inhibitor | |||
| 0.041 | 0.02 | 0.041 | 2,3-Oxidosqualene-lanosterol cyclase inhibitor | |||
| 0.036 | 0.017 | 0.042 | Dipeptidyl peptidase II inhibitor | 0.042 0.013 CID_10890006 | CID_10890006 | |
| 0.07 | 0.051 | 0.07 | Alpha 1a adrenoreceptor antagonist | |||
| 0.031 | 0.012 | 0.031 | CC chemokine 1 receptor antagonist | |||
| 0.131 | 0.113 | 0.131 | Ca2+-transporting ATPase inhibitor | |||
| 0.075 | 0.057 | 0.075 | Estrogen receptor alpha antagonist | |||
| 0.142 | 0.124 | 0.177 | Phospholipase C inhibitor | 0.177 0.064 CID_10890006 | CID_10890006 | |
| 0.141 | 0.125 | 0.141 | Psychostimulant | |||
| 0.165 | 0.15 | 0.165 | Spasmolytic | |||
| 0.079 | 0.064 | 0.079 | Histamine antagonist | |||
| 0.052 | 0.038 | 0.057 | Nicotinic alpha3beta2 receptor antagonist | 0.057 0.03 CID_10890006 | CID_10890006 | |
| 0.037 | 0.023 | 0.037 | p53 inhibitor | |||
| 0.03 | 0.016 | 0.03 | LFA antagonist | |||
| 0.06 | 0.047 | 0.188 | I kappa B kinase 2 inhibitor | 0.188 0.004 CID_10890006 | CID_10890006 | |
| 0.068 | 0.055 | 0.068 | 5 Hydroxytryptamine 1 antagonist | |||
| 0.086 | 0.073 | 0.086 | Glutamate release inhibitor | |||
| 0.044 | 0.032 | 0.055 | Dipeptidyl peptidase IV inhibitor | 0.055 0.015 CID_10890006 | CID_10890006 | |
| 0.049 | 0.037 | 0.05 | Thromboxane A2 antagonist | 0.05 0.036 CID_10890006 | CID_10890006 | |
| 0.05 | 0.038 | 0.05 | 5 Hydroxytryptamine 4 antagonist | |||
| 0.039 | 0.028 | 0.042 | AMPA 4 receptor antagonist | 0.042 0.023 CID_10890006 | CID_10890006 | |
| 0.035 | 0.025 | 0.039 | AMPA receptor agonist | 0.039 0.019 CID_10890006 | CID_10890006 | |
| 0.09 | 0.083 | 0.09 | Estrogen receptor beta antagonist | |||
| 0.058 | 0.053 | 0.058 | 5 Hydroxytryptamine 1B antagonist | |||
| 0.048 | 0.044 | 0.048 | Thromboxane antagonist | 0.048 0.044 CID_10890006 | ||
| 0.037 | 0.033 | 0.04 | Glucagon-like peptide 1 receptor antagonist | 0.04 0.026 CID_10890006 | CID_10890006 | |
| 0.07 | 0.066 | 0.077 | Metalloproteinase-2 inhibitor | 0.077 0.055 CID_10890006 | CID_10890006 | |
| 0.031 | 0.028 | 0.033 | Growth hormone secretagogue receptor antagonist | 0.033 0.026 CID_10890006 | CID_10890006 | |
| 0.027 | 0.025 | 0.027 | Acetylcholine M4 receptor agonist | |||
| 0.059 | 0.056 | 0.077 | Toll-Like receptor 7 antagonist | 0.077 0.04 CID_10890006 | CID_10890006 | |
| 0.021 | 0.019 | 0.021 | Dopamine D1 agonist | |||
| 0.026 | 0.025 | 0.027 | Hedgehog signaling activator | 0.027 0.02 CID_10890006 | CID_10890006 | |
| 0.011 | 0.01 | 0.011 | Glucose-dependent insulinotropic receptor antagonist | 0.011 0.01 CID_10890006 | ||
| 0.014 | 0.013 | 0.014 | NMDA receptor phencyclidine site antagonist | |||
| 0.013 | 0.02 | 0.064 | Alpha 2a adrenoreceptor agonist | 0.064 0.003 CID_10890006 | CID_10890006 | |
| 0.045 | 0.056 | 0.064 | Lysine-specific demethylase 1A inhibitor | 0.064 0.023 CID_10890006 | CID_10890006 | |
| 0.014 | 0.025 | 0.062 | Alpha 2c adrenoreceptor agonist | 0.062 0.003 CID_10890006 | CID_10890006 | |
| 0.045 | 0.057 | 0.052 | Matrix metalloproteinase (membrane-type) inhibitor | 0.052 0.043 CID_10890006 | CID_10890006 | |
| 0.023 | 0.036 | 0.051 | 5 Hydroxytryptamine 6 agonist | 0.051 0.004 CID_10890006 | CID_10890006 | |
| 0.043 | 0.057 | 0.057 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.057 0.033 CID_10890006 | CID_10890006 | |
| 0.02 | 0.047 | 0.037 | Purinergic P2Y14 antagonist | 0.037 0.013 CID_10890006 | CID_10890006 | |
| 0.024 | 0.053 | 0.035 | Cathepsin L1 inhibitor | 0.035 0.033 CID_10890006 | CID_10890006 | |
| 0.045 | 0.074 | 0.162 | 5 Hydroxytryptamine agonist | 0.162 0.019 CID_10890006 | CID_10890006 | |
| 0.054 | 0.083 | 0.066 | Transcription factor RelA inhibitor | 0.066 0.037 CID_10890006 | CID_10890006 | |
| 0.059 | 0.089 | 0.086 | Acetylcholine nicotinic antagonist | 0.086 0.049 CID_10890006 | CID_10890006 | |
| 0.007 | 0.039 | 0.012 | 3 Beta-hydroxy-delta 5-steroid dehydrogenase inhibitor | 0.012 0.01 CID_10890006 | CID_10890006 | |
| 0.025 | 0.056 | 0.05 | ATR kinase inhibitor | 0.05 0.008 CID_10890006 | CID_10890006 | |
| 0.112 | 0.145 | 0.165 | Adenylate cyclase stimulant | 0.165 0.041 CID_10890006 | CID_10890006 | |
| 0.071 | 0.111 | 0.111 | MAP kinase 8 inhibitor | 0.111 0.05 CID_10890006 | CID_10890006 | |
| 0.051 | 0.092 | 0.064 | Beta 3 adrenoreceptor antagonist | 0.064 0.046 CID_10890006 | CID_10890006 | |
| 0.066 | 0.108 | 0.145 | MAP kinase 9 inhibitor | 0.145 0.039 CID_10890006 | CID_10890006 | |
| 0.044 | 0.087 | 0.076 | Neuronal nicotinic receptor antagonist | 0.076 0.039 CID_10890006 | CID_10890006 | |
| 0.059 | 0.105 | 0.212 | I kappa B kinase inhibitor | 0.212 0.007 CID_10890006 | CID_10890006 | |
| 0.087 | 0.135 | 0.142 | Interleukin 8 antagonist | 0.142 0.039 CID_10890006 | CID_10890006 | |
| 0.018 | 0.07 | 0.029 | Complement factor 1s inhibitor | 0.029 0.009 CID_10890006 | CID_10890006 | |
| 0.073 | 0.127 | 0.108 | AMP-activated protein kinase stimulant | 0.108 0.061 CID_10890006 | CID_10890006 | |
| 0.092 | 0.146 | 0.134 | Interleukin 1 antagonist | 0.134 0.072 CID_10890006 | CID_10890006 | |
| 0.036 | 0.092 | 0.058 | Nicotinic receptor alpha7 subunit antagonist | 0.058 0.031 CID_10890006 | CID_10890006 | |
| 0.057 | 0.114 | 0.076 | Acetylcholine agonist | 0.076 0.072 CID_10890006 | CID_10890006 | |
| 0.176 | 0.247 | 0.249 | Ca2+/calmodulin-dependent kinase IV inhibitor | 0.249 0.066 CID_10890006 | CID_10890006 | |
| 0.16 | 0.231 | 0.243 | Insulysin inhibitor | 0.243 0.103 CID_10890006 | CID_10890006 | |
| 0.027 | 0.1 | 0.072 | 5 Hydroxytryptamine 2 agonist | 0.072 0.018 CID_10890006 | CID_10890006 | |
| 0.052 | 0.126 | 0.084 | Keratolytic | 0.084 0.043 CID_10890006 | CID_10890006 | |
| 0.012 | 0.087 | 0.048 | Nicotinic alpha3beta4 receptor agonist | 0.048 0.006 CID_10890006 | CID_10890006 | |
| 0.028 | 0.104 | 0.05 | Acetylcholine M2 receptor agonist | 0.05 0.044 CID_10890006 | CID_10890006 | |
| 0.106 | 0.188 | 0.144 | Ca2+/calmodulin-dependent protein kinase kinase B inhibitor | 0.144 0.084 CID_10890006 | CID_10890006 | |
| 0.125 | 0.207 | 0.18 | Histone acetyltransferase inhibitor | 0.18 0.099 CID_10890006 | CID_10890006 | |
| 0.075 | 0.159 | 0.146 | Sodium channel (voltage-gated) blocker | 0.146 0.057 CID_10890006 | CID_10890006 | |
| 0.045 | 0.132 | 0.088 | Acetylcholine nicotinic agonist | 0.088 0.047 CID_10890006 | CID_10890006 | |
| 0.092 | 0.18 | 0.119 | MAP3K9 inhibitor | 0.119 0.117 CID_10890006 | CID_10890006 | |
| 0.013 | 0.1 | 0.185 | 5 Hydroxytryptamine 2C agonist | 0.185 0.004 CID_10890006 | CID_10890006 | |
| 0.074 | 0.163 | 0.122 | Sodium channel blocker | 0.122 0.082 CID_10890006 | CID_10890006 | |
| 0.025 | 0.117 | 0.053 | Nicotinic neuronal receptor agonist | 0.053 0.042 CID_10890006 | CID_10890006 | |
| 0.052 | 0.148 | 0.103 | Potassium channel activator | 0.103 0.045 CID_10890006 | CID_10890006 | |
| 0.028 | 0.127 | 0.045 | Alpha 1L adrenoreceptor agonist | 0.045 0.025 CID_10890006 | CID_10890006 | |
| 0.027 | 0.139 | 0.045 | Potassium channel (ATP-sensitive) activator | 0.045 0.041 CID_10890006 | CID_10890006 | |
| 0.029 | 0.141 | 0.047 | Potassium channel (Inward rectifier) activator | 0.047 0.042 CID_10890006 | CID_10890006 | |
| 0.021 | 0.137 | 0.079 | 5 Hydroxytryptamine 2B agonist | 0.079 0.005 CID_10890006 | CID_10890006 | |
| 0.069 | 0.19 | 0.155 | Activin receptor-like kinase 2 inhibitor | 0.155 0.063 CID_10890006 | CID_10890006 | |
| 0.044 | 0.173 | 0.09 | Granulocyte macrophage colony stimulating factor antagonist | 0.09 0.084 CID_10890006 | CID_10890006 | |
| 0.137 | 0.269 | 0.195 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | 0.195 0.163 CID_10890006 | CID_10890006 | |
| 0.026 | 0.161 | 0.044 | Histamine H4 receptor antagonist | 0.044 0.042 CID_10890006 | CID_10890006 | |
| 0.065 | 0.2 | 0.095 | Hedgehog signaling inhibitor | 0.095 0.074 CID_10890006 | CID_10890006 | |
| 0.03 | 0.177 | 0.052 | Dihydroorotate oxidase inhibitor | 0.052 0.045 CID_10890006 | CID_10890006 | |
| 0.051 | 0.202 | 0.085 | Bromodomain-containing protein 2 inhibitor | 0.085 0.066 CID_10890006 | CID_10890006 | |
| 0.034 | 0.186 | 0.084 | ALK inhibitor | 0.084 0.054 CID_10890006 | CID_10890006 | |
| 0.029 | 0.184 | 0.073 | Nav1.7 sodium channel blocker | 0.073 0.041 CID_10890006 | CID_10890006 | |
| 0.097 | 0.258 | 0.154 | MAP kinase kinase 4 inhibitor | 0.154 0.055 CID_10890006 | CID_10890006 | |
| 0.024 | 0.194 | 0.062 | Syk tyrosine kinase inhibitor | 0.062 0.058 CID_10890006 | CID_10890006 | |
| 0.006 | 0.186 | 0.027 | Nicotinic alpha4beta2 receptor agonist | 0.027 0.022 CID_10890006 | CID_10890006 | |
| 0.013 | 0.275 | 0.055 | Cyclin A1 inhibitor | 0.055 0.048 CID_10890006 | CID_10890006 | |
| 0.048 | 0.337 | 0.147 | I kappa B kinase epsilon inhibitor | 0.147 0.122 CID_10890006 | CID_10890006 | |
| 0.027 | 0.333 | 0.066 | I kappa B kinase 1 inhibitor | 0.066 0.053 CID_10890006 | CID_10890006 | |
| 0.027 | 0.35 | 0.093 | GABA C receptor antagonist | 0.093 0.089 CID_10890006 | CID_10890006 | |
| 0.018 | 0.361 | 0.085 | Pim-3 kinase inhibitor | 0.085 0.066 CID_10890006 | CID_10890006 | |
| 0.025 | 0.374 | 0.111 | GABA C receptor agonist | 0.111 0.057 CID_10890006 | CID_10890006 | |
| 0.011 | 0.504 | 0.034 | Somatostatin 4 agonist | 0.034 0.031 CID_10890006 | CID_10890006 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |